Arsenault Kaitlyn Melanie's Form 4/A amendment
AmendedSkye Bioscience, Inc. (SKYE) · filed Feb 28, 2025
- Accession no.
- 0001516551-25-000022
- Filed
- Feb 28, 2025
- Trade date
- Nov 15-18, 2024
- Filing delay
- 105 days
- Rule 10b5-1 plan
- Not checked
- Original filed
- Nov 19, 2024
This filing lists 2 non-derivative transactions. Open-market sales total $215.8K. It was filed 105 days after the trade.
This amendment replaces 0001516551-24-000117 (filed Nov 19, 2024).
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Arsenault Kaitlyn MelanieCIK 0001877242 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 15, 2024 | Common Stock | SSaleDisposed | −190 | $5.55 | −$1,054.5 | 210,548 | Direct | |
| Nov 18, 2024 | Common Stock | SSaleDisposed | −43,026 | $4.99F2 | −$214,699.74 | 167,522 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of performance-based restricted stock units. The sales were to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and do not represent discretionary transactions by the Reporting Person.
- F2
The price reported is a weighted average price. These shares were sold as part of a block trade in multiple transactions at prices ranging from $4.98 to $5.08, inclusive. The Reporting Person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price with regard to the block trade.
Referenced by the price of 1 transaction in Table I.
Remarks
This amendment is being filed to correct an inadvertent typographical error in the Original Form 4 in which the number of shares held by the Reporting Person following the transaction was reported as 166,342 instead of 167,522.